Nature CommunicationsHR eye & MMR eye: one-day assessment of DNA repair-defective tumors eligible for targeted therapyShinta SaitoShingo KatoUsaki AraiAtsuki EnJun TsunezumiTaichi MizushimaKensuke TateishiNoritaka Adachi2025-05-12Full textDOI https://doi.org/10.1038/s41467-025-59462-2